Objective: The aim of this retrospective study was to evaluate demographic, etiologic and epidemiologic characteristics, and clinical and laboratory findings of Henoch-Schonlein purpura (HSP) and to determine risk factors increasing the kidney involvement in our region.
INTRODUCTION
Henoch-Schonlein purpura (HSP) is a systemic vasculitis with unknown etiology and characterized by skin, joint, gastrointestinal system (GIS), and kidney involvements (1) . Although HSP can occur in all age groups, it is most commonly encountered in childhood. The annual incidence has been reported as 10-22/100,000. HSP is more common in males and frequently encountered in winter and spring. Although its etiopathogenesis is not well known, infections (bacterial, viral, parasitary), medications, vaccines, tumors, insect bite, and some foods are considered responsible. HSP is generally a self-limiting disease with benign character. The most important factor indicating long-term prognosis is the severity of kidney involvement (2) . The aim of this retrospective study was to evaluate demographic, etiologic and epidemiologic characteristics of HSP and effects of steroid use in preventing kidney involvement and to determine frequency, severity and prognosis of kidney involvement and risk factors in our region.
MATERIALS and METHODS
Records of patients who were followed-up with the diagnosis of HSP between May 2002 and December 2010 in the Department of Child Nephrology in Kocaeli University Medical Faculty were retrospectively evaluated. The patients were re-evaluated based on EULAR/PRINTO/PRES criteria and those having the diagnostic criteria were included (3) . In order to evaluate the records, the patients were informed by phone calls and their consents were obtained.
Patients' data regarding age, gender, season of presentation, complaints on admission, triggering factors, weight, height, blood pressure, pathological examination findings, complete blood count, C-reactive protein level, erythrocyte sedimentation rate, albumin level, blood lipid levels, fecal occult blood (FOB), complete urinalysis, type of treatment (corticosteroids, immunosuppressives, antiaggregants, angiotensin-converting enzyme inhibitors), and follow-up periods.
Hypertension was defined as a systolic and/or diastolic blood pressure of ≥95 percentile based on 3 separate measurements according to age, height, and gender (4). Joint involvement was defined as joint swelling and/or functional limitation of joint and GIS involvement was defined as stomachache and/or FOB positivity and presence of melena, hematemesis, hematochezia, or invagination (5, 6) . Recurrence was defined as new skin rashes developed at least 4 weeks after disease recovery or reoccurrence of other signs (7) . Kidney involvement was defined as microscopic (presence of ≥5 erythrocytes in the centrifuged urine at 40X) or macroscopic hematuria and/or proteinuria (presence of protein >4 mg/m 2 /h or protein/creatinine >0.2 in 24-h urine) and/or impairment in kidney functions (8) .
Testicular sensitivity or scrotal edema was considered as testicular involvement; convulsion and infarction on MRI was considered as central nervous system (CNS) involvement; and presence of ventricular extrasystoles was considered as cardiac involvement.
Statistical analysis
Data were analyzed using SPSS 15.0 (Chicago, IL, USA) program. Descriptive statistics were expressed as mean±standard deviation (minimum-maximum). Univariate analysis and chi-square test were used for categorical variables. Logistic regression and multivariate analysis were performed for probable variables. A p value of <0.05 was considered statistically significant.
RESULTS
Epidemiologic and etiologic features of 151 patients are presented in Table 1 and distribution of clinical findings of the patients is presented in Table 2 .
Rash, mandatory diagnostic criteria, was present in all patients. However, 33 (22%) patients did not have rash on first admission, they were then observed to have rash during the follow-ups.
Of 111 patients having GIS involvement, 50 (33.1%) had only stomachache, 46 (30.4%) had stomachache and FOB positivity, 5 (3.3%) had only FOB positivity, and 1 (0.6%) had invagination.
Joint involvement was present in 87 (57.6%) patients. Ankle (n=49, 32.4%) was involved mostly, followed by knee (n=36, 23.8%) and wrist (n=14, 9.2%) involvements. Joint involvement was commonly in the form of oligoarthritis (41%) and recovered without sequelae.
Steroid treatment was applied to 7 of 13 patients with testicular involvement and 55 of 111 patients with GIS involvement. Steroid treatment was not used for 5 patients as they had BOF positivity on routine tests and for 51 patients as they had mild stomachache that disappeared spontaneously in a few days. Of the patients receiving steroid treatment, 25.8% (n=16) developed kidney involvement and 74.2% (n=46) did not develop. The overall kidney involvement rate was 27.1% (n=41) and previous steroid use had no significant effect on prevention of kidney involvement (χ 2 , p=1.00).
Recurrence was observed in 6 (4%) of 151 patients followed-up with the diagnosis of Henoch-Schonlein purpura. The mean time elapsed from the first attack was 30.6±18 months (range, 2-108 months). The disease recurred in 4 patients in the form of rash and arthritis, in 1 patient in the form of rash and stomachache, in 1 patient in the form of rash. Steroid use was not found to be associated with recurrence (χ 2 , p=1.00).
Kidney involvement was observed in 41 (27.1%) patients. Thirty-six (23.8%) patients had microscopic hematuria and 2 (1.3%) patients had macroscopic hematuria. While 17 (11.2%) patients had only hematuria and 3 (1.9%) patients had only proteinuria, 21 (13.9%) patients had both hematuria and proteinuria. Sixteen Variables considered to affect kidney involvement were evaluated using multivariate analysis. The results are presented in Table 3 . Based on this evaluation, age was found to be the risk factor affecting kidney involvement in HSP (p=0.011). Testicular involvement was found as a negative risk factor (p=0.020).
Kidney biopsy was performed on 15 (35.6%) of 41 patients with kidney involvement. Of the patients undergoing biopsy, 14 had nephrotic proteinuria and 1 had CNS involvement accompanied by nephritic syndrome. According to the classification of kidney involvement by the International Study Kidney Disease in Children, 3 patients had grade 1, 6 patients had grade 2a, 3 patients had grade 2b, 1 patient had grade 3a, 1 patient had grade 3b, and 1 patient had grade 6.
Treatment was applied to 17 patients due to nephrotic proteinuria in 14 patients, CNS involvement in 1 patient, and previous commencement of medication in an external center in 2 patients. Steroid treatment alone was applied to 9 (21.9%) patients; steroid, immunosuppressive and antiaggregant were applied to 6 (14.6%) patients; and steroid, immunosuppressive, antiaggregant, and angiotensin-converting enzyme inhibitor were applied to 2 (4.8%) patients. As an immunosuppressive treatment, 1 patient received azathioprine, 5 patients received cyclophosphamide, and 2 patients received cyclophosphamide followed by cyclosporine A. Two patients were diagnosed with familial Mediterranean fever during the follow-ups. 
DISCUSSION
Henoch-Schonlein purpura is the most common vasculitis both in Turkey and in the world. In the present study, 151 patients with HSP were evaluated in terms of their etiologic, epidemiologic, and clinic characteristics and the findings were compared with those reported from Turkey and other countries (Tables 4 and 5 ) (9-15). The mean age was 7.4±3.4 years (range, 1.8-16.5 years) ( Table 1 ). In terms of the mean age, the present study was observed to be consistent with those reported from Turkey and other countries. Of the study patients, 59.6% were males and 40.4% were females. Male-to-female ratio was 1.47 and this ratio was similar to those in the literature (Tables 4 and 5 ). However, there are also reports indicating that HSP is more frequent in females (14) (15) (16) . In the present study, HSP was most frequent in the winter and least frequent in the summer. In the series from other countries, the disease was reported to be most frequent in winter (Tables  4 and 5 ). Similar to the findings that were reported in the studies from Turkey and other countries, upper respiratory tract infection (URTI) ranked first as the triggering factor. In a prospective study conducted in Finland, streptococcus infection was reported in 36% of the patients (15) .
The lack of rash on admission makes difficult to diagnose HSP and leads to misdiagnosis. In the present study, there were 33 (22%) patients without rash on first admission. While lower rates were determined in the studies in Turkey, the rates of lack of rash on admission were reported at higher rates in the studies from other countries (Tables 4 and 5 ).
In the present study, 73.5% of the patients had GIS involvement. One (0.6%) of our patients had invagination. GIS involvement was reported at a rate between 34% and 62% and between 51% and 73% in the studies from Turkey and other countries, respectively (Tables 4 and 5 ).
Joint involvement was reported at a rate between 38% and 67% and between 67% and 90% in the studies from Turkey and other countries, respectively. In the present study, ankle involvement was the most common, as was reported in the other series.
Coexistence of HSP and FMF has been reported as approximately at a rate of 5% in the literature (17) . This rate was reported as 7.2% and 1.2% in different studies from Turkey (10, 18) . In the present study, while 2 (1.3%) patients were followed-up with the diagnosis of HSP, they were also diagnosed with FMF due to repeated stomachache.
Kidney involvement is the predicting and affecting factor of longterm prognosis of HSP. The rate of kidney involvement in HSP varies between 20% and 60% in different studies (19, 20) . ın the Although kidney involvement has generally good prognosis in HSP, end-stage renal failure can rarely occur. During the follow-up period (mean, 15.6±6.6 months) in the present study, none of the patients had hypertension or renal failure.
In the present study, evaluation of the probable risk factors affecting kidney involvement revealed that age was the only variable increasing risk for kidney involvement. Testicular involvement was detected as the negative risk factor (Table 4 ). This negative association could be attributed to the fact that testicular involvement is encountered in younger ages contrary to kidney involvement. ın the previous studies, risk factors for kidney involvement have been reported as severe purpura, severe stomachache, older age, steroid treatment, moderate kidney involvement at disease onset, and high Factor XIII level in serum (21) (22) (23) (24) (25) . In their study, Anıl et al. (11) reported female gender, atypical onset (without rash), and early steroid treatment as the risk factors for kidney involvement. In the large-scale Finland series, the most reliable study due to its prospective nature, HSP onset above the age of 8 years, stomachache, and recurrence were reported to be the risk factors for kidney involvement (15) . In the present study, no significant relationship of kidney involvement with gender, steroid treatment, musculoskeletal involvement, GIS involvement, and recurrence was found.
Study limitations
Retrospective nature of the present study caused a limitation in the evaluation of data, as is in many studies on this issue.
The present study was similar to other HSP series from Turkey and other countries in terms of number, distribution, and clinical feature of the patients. However, the present study is of importance with respect to consistency of outcomes with those of the published series, proving the disease progression with similar clinical and prognostic features almost anywhere in the world, and providing comparative discussion and review with similar published series.
CONCLUSION
As is seen in similar studies, older age was also found to be a risk factor for kidney involvement in the present study and thereby the importance of kidney involvement should be considered during follow-ups.
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